BidaskClub Lowers GTX (GTXI) to Buy

BidaskClub cut shares of GTX (NASDAQ:GTXI) from a strong-buy rating to a buy rating in a research note released on Wednesday.

GTXI has been the topic of a number of other research reports. Robert W. Baird restated a buy rating and set a $30.00 target price on shares of GTX in a report on Thursday, March 15th. ValuEngine upgraded GTX from a sell rating to a hold rating in a report on Wednesday, February 7th. Zacks Investment Research cut GTX from a hold rating to a sell rating in a report on Wednesday, January 10th. Finally, Stifel Nicolaus raised their target price on GTX from $16.00 to $45.00 and gave the stock a buy rating in a report on Monday, March 5th. Two investment analysts have rated the stock with a hold rating and three have given a buy rating to the stock. The company currently has a consensus rating of Buy and a consensus target price of $37.50.

How to Become a New Pot Stock Millionaire

GTXI stock opened at $19.37 on Wednesday. GTX has a 1-year low of $2.73 and a 1-year high of $23.40.

GTX (NASDAQ:GTXI) last posted its quarterly earnings results on Monday, March 12th. The biopharmaceutical company reported ($0.43) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.48) by $0.05. equities research analysts forecast that GTX will post -1.78 EPS for the current fiscal year.

In other GTX news, insider Jason T. Shackelford sold 3,090 shares of the firm’s stock in a transaction dated Friday, January 5th. The stock was sold at an average price of $11.33, for a total transaction of $35,009.70. Following the transaction, the insider now owns 31,111 shares in the company, valued at $352,487.63. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, VP Henry Patton Doggrell sold 4,965 shares of the firm’s stock in a transaction dated Friday, January 5th. The stock was sold at an average price of $11.33, for a total value of $56,253.45. Following the transaction, the vice president now owns 54,804 shares in the company, valued at approximately $620,929.32. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 15,364 shares of company stock worth $174,074. Company insiders own 41.20% of the company’s stock.

A number of institutional investors and hedge funds have recently modified their holdings of GTXI. Abingworth LLP acquired a new stake in shares of GTX during the third quarter worth about $2,781,000. Caxton Corp acquired a new stake in shares of GTX during the third quarter worth about $531,000. Millennium Management LLC acquired a new stake in shares of GTX during the fourth quarter worth about $749,000. Finally, EAM Investors LLC acquired a new stake in shares of GTX during the fourth quarter worth about $551,000. Hedge funds and other institutional investors own 12.71% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This news story was originally reported by Ticker Report and is the sole property of of Ticker Report. If you are accessing this news story on another site, it was stolen and reposted in violation of United States & international copyright & trademark law. The legal version of this news story can be viewed at https://www.tickerreport.com/banking-finance/3295697/bidaskclub-lowers-gtx-gtxi-to-buy.html.

About GTX

GTx, Inc, a biopharmaceutical company, engages in the discovery, development, and commercialization of small molecules for the treatment of breast and prostate cancer, and other medical conditions. It focuses on the development of selective androgen receptor modulators (SARMs) for the treatment of breast cancer, stress urinary incontinence (SUI), and Duchenne muscular dystrophy (DMD); and selective androgen receptor degraders (SARDs) to treat progressive castration-resistant prostate cancer (CRPC).

Receive News & Ratings for GTX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GTX and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Critical Comparison: Cypress Energy Partners  and RPC
Critical Comparison: Cypress Energy Partners and RPC
Head to Head Analysis: Intrepid Potash  and Emerge Energy Services
Head to Head Analysis: Intrepid Potash and Emerge Energy Services
Tenaris  vs. Its Rivals Critical Survey
Tenaris vs. Its Rivals Critical Survey
Zacks: Analysts Expect Nexstar Media Group Inc  Will Post Quarterly Sales of $617.81 Million
Zacks: Analysts Expect Nexstar Media Group Inc Will Post Quarterly Sales of $617.81 Million
Onix Price Tops $0.0109
Onix Price Tops $0.0109
Netko  Reaches Market Capitalization of $1.01 Million
Netko Reaches Market Capitalization of $1.01 Million


© 2006-2018 Ticker Report. Google+.